Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.550
+0.320 (7.57%)
At close: Jan 9, 2026, 4:00 PM EST
4.417
-0.133 (-2.93%)
After-hours: Jan 9, 2026, 7:13 PM EST

Tvardi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.01-5.430.020.01
Quick Ratio
3.303.056.9910.23
Current Ratio
3.483.067.9710.31
Return on Equity (ROE)
-135.64%-329.99%-54.30%-
Return on Assets (ROA)
-72.68%-56.48%-32.36%-
Return on Capital (ROIC)
-105.82%-72.07%-36.05%-
Return on Capital Employed (ROCE)
-107.10%-113.20%-78.70%-51.90%
Buyback Yield / Dilution
-170.52%-0.31%-0.09%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q